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A specific cyclic ADP-ribose antagonist inhibits cardiac
excitation–contraction coupling
Stevan Rakovic*, Antony Galione*, Gloria A. Ashamu†, 
Barry V.L. Potter† and Derek A. Terrar*
Background: Cyclic ADP-ribose (cADPR) has been shown to act as a potent
cytosolic mediator in a variety of tissues, regulating the release of Ca2+ from
intracellular stores by a mechanism that involves ryanodine receptors. There is
controversy over the effects of cADPR in cardiac muscle, although one possibility
is that endogenous cADPR increases the Ca2+ sensitivity of Ca2+-induced Ca2+
release (CICR) from the sarcoplasmic reticulum. We investigated this possibility
using 8-amino-cADPR, which has been found to antagonize the Ca2+-releasing
effects of cADPR on sea urchin egg microsomes and in mammalian cells
(Purkinje neurons, Jurkat T cells, smooth muscle and PC12 cells).
Results: In intact cardiac myocytes isolated from guinea-pig ventricle, cytosolic
injection of 8-amino-cADPR substantially reduced contractions and Ca2+
transients accompanying action potentials (stimulated at 1 Hertz). These
reductions were not seen with injection of HEPES buffer, with heat-inactivated
8-amino-cADPR, or in cells pretreated with ryanodine (2 mM) to suppress
sarcoplasmic reticulum function before injection of the 8-amino-cADPR. L-type
Ca2+ currents and the extent of Ca2+ loading of the sarcoplasmic reticulum were
not reduced by 8-amino-cADPR. 
Conclusions: These observations are consistent with the hypothesis that
endogenous cADPR plays an important role during normal contraction of cardiac
myocytes. One possibility is that cADPR sensitizes the CICR mechanism to
Ca2+, an action antagonized by 8-amino-cADPR (leading to reduced Ca2+
transients and contractions). A direct effect of 8-amino-cADPR on CICR cannot
be excluded, but observations with caffeine are not consistent with a non-
selective block of release channels. 
Background
Changes in cytosolic Ca2+ provide an important sig-
nalling mechanism for the regulation of a great diversity
of cell functions; it is believed that the release of Ca2+
from intracellular stores plays a major role in generating
these signals. In recent years, evidence has accumulated
supporting the hypothesis that the endogenous mol-
ecule, cyclic ADP-ribose (cADPR), modulates Ca2+
release from intracellular stores in a variety of cell types
[1–5]. The pharmacology of cADPR-induced Ca2+
release is consistent with a mechanism of action that
involves the ryanodine receptor Ca2+-release channel. As
it is well known that the ryanodine receptor plays a
crucial role in Ca2+-induced Ca2+ release (CICR) from
the sarcoplasmic reticulum in cardiac muscle [6], we
investigated the possible role of cADPR in the regula-
tion of the cardiac ryanodine receptor during excita-
tion–contraction coupling in the heart. Although such a
regulatory role for cADPR has not yet been established
in the heart, the enzymes for synthesis and degradation
of cADPR are known to be present in cardiac muscle [7],
and endogenous concentrations of approximately 200 nM
have been reported [8]. It has been shown recently that
cADPR promotes the release of Ca2+ from isolated
cardiac sarcoplasmic reticulum [9], but other studies have
failed to demonstrate such effects [10] or have found
actions which appear to be antagonized by ATP at con-
centrations expected to be present in the cytoplasm of
intact cells [11].
One experimental tool for the study of cADPR mecha-
nisms is its 8-amino derivative; this has been shown to be
a competitive antagonist of cADPR both in sea urchin egg
preparations [12] and in mammalian cells (Purkinje
neurons [13], Jurkat T cells [14], intestinal smooth
muscle cells [15] and PC12 cells [16]). To further investi-
gate the possibility that endogenous cADPR may modu-
late excitation–contraction coupling in cardiac muscle, we
have studied the effects of 8-amino-cADPR on Ca2+ tran-
sients and contractions of guinea-pig ventricular cells.
Preliminary observations have been presented to The
Physiological Society [17].
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Results
Single cardiac myocytes were isolated from guinea-pig
ventricle and impaled with double-barrelled ‘theta-glass’
sharp microelectrodes, allowing one barrel to be used for
electrical recording, and the other for cytosolic application
of drugs (after obtaining a series of measurements in the
absence of drug). In the first set of experiments, Ca2+-
dependent inward currents were used to report cytosolic
Ca2+, allowing Ca2+ transients to be monitored. Cell short-
ening was measured from the video image of cells using
an edge-detection system. (Details of these techniques
are given in the Materials and methods section). Figure
1a shows the effects of cytosolic injection of 8-amino-
cADPR (at a pipette concentration of 20 mM) on Ca2+
transients in 15 cells stimulated to fire action potentials at
1 Hertz. 8-amino-cADPR caused a substantial reduction
of the Ca2+ transient within 3 minutes of application, with
a slightly greater degree of suppression evident at
8 minutes: after 3 minutes, the peak (at 50 milliseconds)
was reduced to 68 ± 3 % that of control (p < 0.05), and
after 8 minutes the peak magnitude was 59 ± 3 % of the
pre-drug value. Quantitatively similar effects of 8-amino-
cADPR on the magnitude of cell contraction were
observed in 13 of these 15 cells (Fig. 1b; contraction mea-
surements could not be made in two cells because of poor
image quality): the peak magnitude of cell shortening rel-
ative to control was 70 ± 4 % at 3 minutes and 62 ± 5% at
8 minutes (p < 0.05). The reductions in Ca2+ transients
and contractions were comparable, although slightly less
than those seen with ryanodine to suppress CICR under
similar conditions (see below). The residual contraction
may be largely supported by Ca2+ influx through the sar-
colemma (see later). The effects of 8-amino-cADPR on
Ca2+ transients and contraction were not accompanied by
any significant changes in action potential duration (see
Fig. 1, legend).
Heat treatment (above 70 °C for 2 hours) of 8-amino-
cADPR abolished its ability to antagonise the Ca2+ releas-
ing actions of cADPR in sea urchin egg preparations (data
not shown). Application of heat-inactivated 8-amino-
cADPR was therefore used in control experiments in
cardiac myocytes to test for possible effects of the injec-
tion method or time. Figure 2 shows the effects of applica-
tion of the heat-treated solution in amounts equivalent to
20 mM 8-amino-cADPR (mean of seven cells). The
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Figure 1
Suppression of Ca2+ transients and
contraction by 8-amino-cADPR applied to the
cytosol. (a) Effect of 8-amino-cADPR, at a
pipette concentration of 20 mM, on Ca2+
transients (constructed from the magnitudes
of Ca2+-activated currents). 8-amino-cADPR
caused a significant reduction in the
magnitude of the Ca2+ transient at both 3 min
and 8 min following cytosolic application.
Each point is the mean of 15 cells; error bars
represent standard errors of the mean. All
points are significantly different from control
(p < 0.05). (b) Effect of 20 mM 8-amino-
cADPR on cell contraction in 13 of these 15
cells. 8-amino-cADPR injection resulted in a
significant reduction (p < 0.05) in the peak
magnitude of cell contraction with no
observable effect on the time to peak. Action
potential duration (measured at 90 %
repolarization, APD90) was not significantly
altered by 8-amino-cADPR in these
experiments (267 ± 14 msec before and
262 ± 19 msec after 8-amino-cADPR).
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(a) Calcium-activated current (n = 15) (b) Cell contraction (n = 13)
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cytosolic application of heated 8-amino-cADPR was
without significant effect (p > 0.05) on both the Ca2+ tran-
sient and cell contraction: at 3 and 8 minutes, the peak of
the steady state Ca2+ transient was 102 ± 2 % and
102 ± 2 % of that before injection, and cell shortening was
99 ± 6 % and 99 ± 8 % of the pre-injection value. Action
potential durations at 90 % repolarization were also
unchanged in these seven cells (255 ± 20 milliseconds
before, and 257 ± 16 milliseconds after cytosolic applica-
tion of heat-treated 8-amino-cADPR). In another series of
control experiments, cells were injected with HEPES
buffer which did not contain 8-amino-cADPR; again there
was no significant effect on Ca2+ transients (11 cells) or on
contraction (9 cells) 8 minutes after cytosolic application
(the peak of the Ca2+ transient was 103 ± 10% of that
before injection of HEPES, and peak cell shortening was
99 ± 2 % that of the control value).
The suppression by 8-amino-cADPR of the peak magni-
tude of the Ca2+ transient was found to exhibit a concen-
tration-dependence over the range 200 nM to 20 mM
(pipette concentration), as shown in Figure 3. A similar
concentration-dependence was observed for the decrease
in cell contraction (Fig. 3). Note that the concentrations in
the cytosol are expected to be much lower than those in
the pipette, as access to the cytosol from these sharp elec-
trodes is expected to be restricted (see Materials and
methods). Some variability in the ratio of pipette-to-
cytosol concentrations is also likely between experiments
as, for example, the precise dimensions of the microelec-
trode tip may influence access of the drug from the
pipette to the cytosol. Nevertheless, it is clear that con-
centration dependence was observed, despite these
limitations.
In a further set of experiments, the Ca2+ sensitive dye
fura-2 was used to monitor Ca2+ transients in cells injected
with 8-amino-cADPR (see Materials and methods for
details). Figure 4 shows the 340/380 fluorescence ratio
before and 8 minutes after the injection of 5 mM or 20 mM
8-amino-cADPR. These data are in general agreement
with those obtained from the magnitudes of Ca2+-acti-
vated tail currents: 20 mM 8-amino-cADPR was found to
cause a large decline in the magnitude of the Ca2+ tran-
sient (five cells), with a smaller suppressive action evident
for 5 mM 8-amino-cADPR (seven cells).
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Figure 2
Lack of effect of heat-treated 8-amino-cADPR
on Ca2+ transients and contraction. (a) Effect
on Ca2+ transients (constructed from the
magnitudes of Ca2+-activated currents) of
injection of 20 mM (pipette concentration) 8-
amino-cADPR which had been heated to
above 70 °C for 2 h. Heated 8-amino-cADPR
caused no significant reduction in the
magnitude of the Ca2+ transient at both 3 min
and 8 min following cytosolic application.
Each point is the mean of 7 cells; error bars
represent standard errors of the mean. (b)
Effect of heated 20 mM 8-amino-cADPR on
cell contraction in these 7 cells. Heated 8-
amino-cADPR injection was without
significant effect on both the peak magnitude
of cell contraction and time to peak. APD90
was 255 ± 20 msec before and
257 ± 16 msec after the application of heated
8-amino-cADPR.
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To investigate whether the observed reduction of Ca2+
transients and contractions by 8-amino-cADPR might be
due to an influence on Ca2+ entry through L-type Ca2+
channels, L-type Ca2+ currents were compared before and
after injection of 20 mM 8-amino-cADPR. Figure 5a
shows representative examples of Ca2+ currents recorded
before and after injection of 20 mM 8-amino-cADPR
(these currents were evoked by 200 millisecond step
depolarizations from –40 to 0 mV). The current–voltage
relations for peak Ca2+ current, averaged from six cells,
are plotted in Figure 5b. 8-amino-cADPR was without
significant effect on the current–voltage relation, demon-
strating that its suppression of Ca2+ transients and con-
tractions was not attributable to an action on Ca2+ entry
from the extracellular space through sarcolemmal Ca2+
channels.
To test whether the suppressive actions of 8-amino-
cADPR might be due to an action at the level of Ca2+
release from intracellular stores, the effects of 20 mM 8-
amino-cADPR were studied in cells exposed to 2 mM
ryanodine to inhibit the functioning of the sarcoplasmic
reticulum [18–20]. As shown in Figure 6, ryanodine
markedly suppressed Ca2+ transients and associated con-
tractions in cells stimulated to fire action potentials, and
increased the time to peak of the former. Subsequent
injection of 8-amino-cADPR in the continued presence of
ryanodine was without significant further effect on either
the time to peak or the magnitude of the Ca2+ transient
and cell contraction (Fig. 6). These observations are there-
fore consistent with an inhibitory action of 8-amino-
cADPR on the Ca2+ transient (in the absence of
ryanodine) as a consequence of reduced Ca2+ release from
the sarcoplasmic reticulum; this inhibitory action is pre-
vented by ryanodine, which suppresses release from Ca2+
stores. As the majority of the calcium-activated current is
carried by Na+:Ca2+ exchange, the lack of effect of 8-
amino-cADPR on calcium-activated currents in the pres-
ence of ryanodine would exclude any direct effects of
8-amino-cADPR on the Na+:Ca2+ exchanger.
To determine whether the inhibitory action of 8-amino-
cADPR on the Ca2+ transient and cell contraction might
involve a reduction in the quantity of Ca2+ available for
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Figure 3
Concentration-dependent suppression of peak Ca2+-activated tail
currents and peak cell contraction by 8-amino-cADPR. Ca2+-activated
currents were measured for action potentials abbreviated at 50 msec
(peak level). Measurements were made 8 min after injection. All points
were significantly different from pre-drug values (p < 0.05), with the
exception of contraction in the presence of 1 mM 8-amino-cADPR (‡).
The number of cells studied for each concentration were: n = 5 for
200 nM; n = 5 for 1 mM; n = 7 for 5 mM; and n = 13 for 20 mM.
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Figure 4
Suppression by 8-amino-cADPR of Ca2+ transients, as measured with
fura-2. (a) Effect of 8-amino-cADPR, at a pipette concentration of
5 mM, on Ca2+ transients measured from the fluorescence of fura-2.
Single myocytes were illuminated with excitation light of wavelength
340 ± 5 or 380 ± 5 nm, and emitted fluorescent light collected at
500 ± 40 nm. Each of the above traces (mean of 7 cells) was
constructed from the ratio of fluorescence intensity at 340 nm
excitation to that at 380 nm excitation; upward deflections indicate a
rise in cytosolic Ca2+. 5 mM 8-amino-cADPR caused a small reduction
in the magnitude of the Ca2+ transient 8 min after injection. (b) In 5
other cells, injection of 20 mM 8-amino-cADPR was found to be
associated with a greater suppression of the Ca2+ transient, as
monitored from the fluorescence of fura-2.
(a) 5 µM 8-amino-cADPR (n = 7) (b) 20 µM 8-amino-cADPR (n = 5)
300 msec
Control
5 µM 8-amino-cADPR 
(8 min)
Control
20 µM 8-amino-cADPR 
(8 min) 
release from intracellular stores, contractions in response
to rapid applications of caffeine were monitored [21].
Cytosolic application of 8-amino-cADPR (20 mM in the
pipette) did not reduce caffeine-induced contractions,
even though, in the same cells, it did suppress Ca2+ tran-
sients and cell contractions accompanying action poten-
tials (as in Fig. 1). Indeed, there was a small, but
statistically significant (p < 0.05), increase in the magni-
tude of the contractile response to caffeine (from
13.2 ± 1.4 % to 15.1 ± 1.3 %, expressed as a percentage of
resting length; n = 7). This increase may be associated
with a slight enhancement of the amount of Ca2+ available
for release from the sarcoplasmic reticulum when the
release process is inhibited by 8-amino-cADPR. Thus, the
inhibitory effects of 8-amino-cADPR on Ca2+ transients
and cell contraction cannot be accounted for by a reduc-
tion in the degree of loading of intracellular stores (as
assessed using this method).
Discussion
The observations presented above demonstrate that 8-
amino-cADPR can suppress Ca2+ transients, without
reducing sarcolemmal Ca2+ currents and without depleting
intracellular Ca2+ stores. The ability of ryanodine to
abolish these effects is consistent with an action of the
compound at the level of the sarcoplasmic reticulum. It is
possible that 8-amino-cADPR could act to inhibit Ca2+-
induced Ca2+ release by a mechanism which does not
depend on the action of cADPR, for example at sites on
the ryanodine receptor normally bound by other
nucleotides. However, in view of the evidence that 8-
amino-cADPR antagonizes cADPR-induced but not caf-
feine-induced Ca2+ release, and also competitively inhibits
[32P]-cADPR binding to sea urchin microsomes [12], it is
more likely that 8-amino-cADPR acts as a selective
inhibitor at the cADPR-binding site without blocking
ryanodine receptor activation by pharmacological agents
such as caffeine.
Further support for this interpretation is provided by
experiments showing an antagonism by 8-amino-cADPR
of cADPR action in mammalian cells, including neurons
[13], T-lymphocytes [14], intestinal smooth muscle cells
[15] and PC12 cells [16]. In addition, 8-amino-cADPR did
not reduce Ca2+ release from the sarcoplasmic reticulum
by caffeine in the experiments reported here. The most
probable explanation for the observed effects of 8-amino-
cADPR in cardiac ventricular muscle, therefore, is an inhi-
bition of the action of endogenous cADPR. These data
provide the first direct evidence that endogenous cADPR
plays an important role in regulating Ca2+ release from the
sarcoplasmic reticulum in intact myocytes, perhaps by
modulating the sensitivity to Ca2+ of the release channel,
and hence may exert a strong influence on the force of
contraction of cardiac ventricular cells.
As mentioned above, the enzymes for synthesis and degra-
dation of cADPR have been shown to be present in
cardiac muscle [7,22], and it has been estimated that
cADPR is present in cardiac cells at a concentration of
200 nM [12]. However, the mechanisms regulating
cADPR levels in cardiac cells have not yet been eluci-
dated. In the sea urchin egg, there is evidence that nitric
oxide, acting through a rise in cytosolic cGMP, may stimu-
late the production of cADPR [4]. In pancreatic b cells,
glucose-induced increases in cytosolic cADPR may play a
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Figure 5
Lack of effect of 8-amino-cADPR on Ca2+
entry via L-type Ca2+ channels. (a) The upper
panel illustrates the 200 msec step
depolarization to 0 mV, from a holding
potential of –40 mV, used to evoke L-type
Ca2+ currents such as those shown in the
lower panel. The data shown in this figure are
taken from a representative cell, and show a
lack of effect of 20 mM 8-amino-cADPR
(8 min after injection) on both the peak
magnitude and on the rate of decay of L-type
Ca2+ current. (b) Effects of 8-amino-cADPR
(at a pipette concentration of 20 mM) on the
current-voltage relation for peak L-type Ca2+
current, recorded during step depolarizations
from a holding potential of –40 mV (to
inactivate sodium channels and T-type Ca2+
channels) to a range of potentials from –30 to
+40 mV. At both 3 min and 8 min, 8-amino-
cADPR was without significant effect on peak
current over the potential range tested.
(a) (b)
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role in stimulus-secretion coupling [23,24]. Another
possible regulatory mechanism has been identified in
mammalian intestinal longitudinal smooth muscle, where
cholecystokinin-8 has been reported to enhance cADPR
synthesis [15]. Possible roles of such regulatory factors in
cardiac muscle remain for future study. A summary
scheme to represent possible regulation of CICR by
cADPR in cardiac muscle is shown in Figure 7.
Release of Ca2+ from the sarcoplasmic reticulum plays an
important role not only during normal cardiac muscle con-
traction but also during abnormal conditions that lead to
Ca2+ overload and oscillations of cell Ca2+ and membrane
potential. These oscillations are thought to arise from
cyclic release from, and uptake into, the sarcoplasmic
reticulum stores, and are believed to underlie a variety of
disturbances of the rhythm of the heart [25]. It is as yet
unknown whether these oscillations are influenced by
cytosolic levels of cADPR. Preliminary experiments
reported by us to the joint meeting of Japanese and
British Physiological Societies support this possibility, as
8-amino-cADPR (20 mM in the pipette) was able to sup-
press oscillations provoked by exposure of guinea-pig
ventricular myocytes to high concentrations of isopro-
terenol or ouabain [26].
If, as suggested, Ca2+ transients and therefore contractions
are indeed influenced by endogenous levels of cADPR,
the intriguing possibility is raised that novel inotropic
agents might be developed to act at the cADPR receptor
in the sarcoplasmic reticulum. In addition, if cADPR were
to influence the Ca2+ oscillations mentioned above, novel
analogues of 8-amino-cADPR and cADPR may prove to
be useful as potential antiarhythmic drugs, and establish-
ment of the cADPR signalling pathway will provide yet
more drug targets.
Conclusions
8-amino-cADPR applied to the cytosol of intact
myocytes isolated from guinea-pig ventricle suppresses
Ca2+ transients and cell contractions, by reducing release
of Ca2+ from the sarcoplasmic reticulum. A direct effect
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Figure 6
Lack of effect of 8-amino-cADPR on Ca2+
transients and contraction following
pretreatment with ryanodine. (a) Effect of 8-
amino-cADPR, at a pipette concentration of
20 mM, on Ca2+ transients (constructed from
the magnitudes of Ca2+-activated currents)
following exposure of cells to 2 mM ryanodine
(applied in the solution bathing the cells).
Ryanodine itself caused a marked reduction in
the Ca2+ transient at all times (peak being
reduced to 45 ± 3 % of control, p < 0.05),
and increased the time to peak from
48 ± 3 msec to 118 ± 10 msec. Subsequent
injection of 8-amino-cADPR (in the continued
presence of ryanodine) was without
significant further effect (peak magnitude
42 ± 5 % of the control value; time to peak
124 ± 10 msec). Each point is the mean of 5
cells; error bars represent standard errors of
the mean. (b) In the same 5 cells, ryanodine
caused a large reduction in the magnitude of
cell contraction (to 21 ± 4% of control) with
no significant effect on the time to peak
(137 ± 3 msec before and 140 ± 5 msec after
ryanodine). Subsequent cytosolic application
of 8-amino-cADPR was without significant
effect at both 3 min and 8 min (amplitude
19 ± 5 % of control, and time to peak
153 ± 11 msec). 
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of 8-amino-cADPR on CICR cannot be excluded,
although observations with caffeine are not consistent
with non-selective block of release channels. However,
in view of evidence from sea urchin preparations and
mammalian cells (Purkinje neurons, Jurkat T cells, longi-
tudinal smooth muscle cells and PC12 cells), that 8-
amino-cADPR acts as a competitive antagonist of
cADPR, it seems more likely that the above observations
result from reduction of an enhancing influence of
endogenous cADPR on CICR from cardiac sarcoplasmic
reticulum.
Materials and methods
Cell isolation and superfusion
Guinea-pigs were killed by cervical dislocation following stunning; the
heart was excised, perfused with solution containing collagenase, and
myocytes were isolated by methods described previously [27,28].
Cells were superfused with a balanced salt solution (36 °C, pH 7.4,
equilibrated with 95 % O2/ 5 % CO2) containing 118.5 mM NaCl,
4.2 mM KCl, 1.18 mM KH2PO4, 1.18 mM MgSO4.7H2O, 2.5 mM
CaCl2, and 11.1 mM glucose. 
Electrical recording and drug application
Microelectrodes were pulled from theta glass tubing, with one barrel
containing electrolyte (4 M KMeSO4 and 10 mM KCl) for recording,
and the other barrel used for application of drugs [29,30]. The drug
application barrel was initially empty, and records could be taken
from the myocyte with the electrode in place in the cell; drug-contain-
ing solution was then added to the top of the application barrel and
travelled rapidly to the tip by capillary action. The drug entered the
cell by diffusion. The times of exposure to drugs are quoted from the
time of application of drug-containing solution to the application
barrel. All drugs applied intracellularly were dissolved in 20 mM
HEPES buffer, pH 7.3.
The recording barrel of the microelectrode was attached to an
Axoclamp 2A recording system. Current clamp recording was used for
action potentials (2 msec stimuli at 1 Hz), while ‘switched’ voltage-
clamping was used for calcium currents (cells were clamped at a
holding potential of –40 mV to inactivate sodium current, and calcium
currents were evoked by application of 200 msec step depolarizations
to a range of potentials from –30 to +40 mV, at a frequency of 0.3 Hz). 
Measurement of cell contraction
Cell contraction was monitored from the video image of cells viewed
microscopically using an edge detection system (Brian Reece Scien-
tific, Abingon, UK); time resolution was 20 msec per point, and length
resolution across the screen was 1 in 1024 pixels. 
Measurement of cytosolic Ca2+ transients
Two methods were used for measurement of cytosolic calcium tran-
sients. In the first, Ca2+-activated inward currents (predominantly
Na+:Ca2+ exchange current perhaps with calcium-activated cation
channel current) were recorded by interrupting action potentials with a
voltage-clamp to –70 mV at various times after the upstroke; the cur-
rents recorded under these conditions (after rapid decay of capacity
current and de-activating calcium currents) reflect calcium beneath the
membrane and are abolished by the calcium chelator BAPTA [30].
Care was taken to ensure a steady state loading of stores by allowing
at least four full action potentials before interruption. In the second set
of experiments, cytosolic Ca2+ was measured with the fluorescent indi-
cator fura 2: excitation was via a quartz fibre optic at 340 ± 5 nm and
380 ± 5 nm, and collection was at 500 ± 20 nm [31]. Cells for fluores-
cence measurement had been loaded with 5 mM fura-2-AM for 20 min.
In the steady state (before and after addition of a drug), fluorescence
signals were very consistent in response to successive stimuli, and
switching of wavelength was therefore carried out between action
potentials. Eight responses were averaged at each wavelength (the
sequence being four responses at 340 nm, eight at 380 nm and four at
340 nm). When compared in the same cells, the fluorescence method
gave good agreement with that using Ca2+-activated currents, although
the calcium transients were appreciably slowed by the fura-2 loading,
most likely a result of the calcium buffering actions of fura-2 [31].
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Figure 7
Hypothetical scheme for a role of cADPR in
cardiac ventricular myocyte
excitation–contraction coupling. The majority
of calcium which activates the contractile
apparatus is released from the sarcoplasmic
reticulum in response to a small influx of
trigger calcium through L-type calcium
channels in the sarcolemma. This
phenomenon, termed Ca2+ -induced Ca2+
release (CICR), is mediated via ryanodine
receptors (RyRs). cADPR may sensitize RyRs
to Ca2+ and therefore enhance CICR and
cardiac contractility. This influence of cADPR
may be either direct, or involve putative
cADPR-binding proteins (cADPR-BPs); a
requirement for calmodulin (CaM) has also
been proposed. cADPR is synthesized from
b-NAD+ by ADP-ribosyl cyclases (C; yellow).
These enzymes are often bifunctional, also
possessing the ability to hydrolyze cADPR to
the inactive metabolite ADP-ribose (H,
hydrolase; yellow). Phosphorylation of these
enzymes may be an important way of
regulating cADPR synthesis. The action of
Ca2+-ATPase reloads the store with Ca2+. ?
? C H
cADPR
ADPRNAD+
Ca2+
Ca2+-ATPase
Ca2+
cADPR-BP
CaM
RyR
Ca2+ channel
Sarcoplasmic reticulum
Cytoplasm
Extracellular space
Contractile
myofilaments
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Rapid application of caffeine
In some experiments, cell contraction in response to rapid and transient
application of 50 mM caffeine was used as a measure of the loading of
intracellular calcium stores. The rapid application of a high dose of caf-
feine is thought to result in the opening of ryanodine receptors in the
sarcoplasmic reticulum, and hence the release of calcium from intracel-
lular stores which in turn leads to cell shortening [21]. Rapid application
of caffeine was achieved by pressure ejection (for 1–2 sec) of 50 mM
caffeine from a micropipette positioned close to the cell under study.
Drugs
Ryanodine was obtained from Calbiochem, caffeine from Sigma. 8-
amino-cADPR was synthesized by methods described previously [32]
using several modifications of the method of Walseth and Lee [12]. 8-
amino-cADPR was initially synthesized by coupling 8-amino-AMP (pre-
pared by reduction of 8-azido-AMP with dithiothreitol) with nicotinamide
mononucleotide in 75 % aqueous pyridine using dicyclohexylcarbodi-
imide. The product was purified by ion-exchange chromatography (as
below) and was used for the next stage as its triethylammonium salt.
Incubation with crude Aplysia ADP-ribosyl cyclase was monitored by
HPLC and when cyclization was judged to be complete the 8-amino-
cADPR was purified by ion-exchange chromatography on Sepharose Q
Fast Flow using a gradient of triethylammonium bicarbonate; the 8-
amino-cADPR was used as its triethylammonium salt. After quantifica-
tion by UV spectroscopy, the compound was thoroughly characterized
by spectroscopic techniques and its purity assessed by HPLC.
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